Eurand to Be Issued US Patent for Amrix(r).
Eurand has out-licensed North American marketing rights to Cephalon, while it retains ex-North American marketing rights. According to IMS, Cyclobenzaprine HCl is the most widely prescribed muscle relaxant in the U.S., representing 37 percent of the 45 million prescriptions written for muscle relaxants in 2006.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four partnered products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Eurand has completed two phase III clinical trials on its lead product candidate, Zentase, intended for the treatment of Exocrine Pancreatic Insufficiency and has submitted an NDA for this product.